Medication info
Jaitra Tablet

Jaitra Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Bivozon Pharmaceutical Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200805085 · Notified 2008.05.02 · Insurance code 658201830

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether continued treatment with this medicine is appropriate. Elderly Use the usual adult dose. However, when tramadol is administered orally to elderly patients aged 75 years and older, the elimination half-life of tramadol increases by 17%; therefore, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance below 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether continued treatment with this medicine is appropriate.

Ingredients

Manufacturer
Bivozon Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate acute pain
  • moderate chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether continued treatment with this medicine is appropriate. Elderly Use the usual adult dose. However, when tramadol is administered orally to elderly patients aged 75 years and older, the elimination half-life of tramadol increases by 17%; therefore, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance below 10ml/min). Since tramadol is removed very slowly during hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether continued treatment with this medicine is appropriate.

Precautions

This medication may burden the liver, so individuals who frequently consume more than a certain amount of alcohol daily should consult a doctor or pharmacist before taking it. If any rash or allergic reaction occurs while taking this medication, discontinue it immediately and consult healthcare professionals. Due to the risk of seizures, caution is needed if there is a history of seizures or if other medications that may induce seizures are being taken. Serious allergic reactions such as anaphylaxis may occur rarely, so if sudden shortness of breath or rash develops, seek emergency treatment immediately. Patients with severe respiratory diseases may experience increased difficulty in breathing while taking this medication and should be monitored by healthcare professionals. Taking this medication with alcohol or central nervous system depressants can lead to severe drowsiness, respiratory depression, and coma, so combination should be avoided. Patients with brain injuries or increased intracranial pressure may experience worsening symptoms while taking this medication, so caution is required. This medication can lead to physical and psychological dependence; therefore, dosage and duration should be adjusted according to the instructions of a medical professional for long-term use. Patients with impaired liver function must consult a doctor before taking this medication and adhere to recommended doses to minimize the risk of liver damage. The metabolism rate of this medication may be higher in individuals with certain genetic characteristics, increasing the risk of side effects such as respiratory depression; caution is needed when taking. This medication should not be administered to children under 12 years or adolescents under 18 years after certain surgeries, and special caution is necessary for pediatric patients. Patients with sleep apnea or symptoms of hypoxia may experience worsening symptoms after taking this medication and need continuous monitoring. Elderly patients or those at risk of hyponatremia should be monitored closely for symptoms of hyponatremia while taking this medication. This medication should not be administered to certain patients, especially those with severe respiratory depression, significant liver, kidney, or heart dysfunction, or those with substance abuse issues. Sudden discontinuation during treatment can lead to withdrawal symptoms, so the dosage should be tapered gradually according to the doctor's instructions. This medication has many interactions with other drugs, so if you are taking other medications, be sure to inform the healthcare provider, especially if using antidepressants, anticonvulsants, or narcotic pain relievers. Drowsiness or dizziness may occur due to this medication during driving or operating machinery, so caution is advised. Overdose can lead to severe respiratory depression, seizures, liver damage, etc., so adherence to dosing guidelines is essential, and immediate medical attention should be sought if symptoms arise. Keep this medication in a secure place out of the reach of children and ensure that others do not take it without a prescription.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, fatal respiratory suppression, hyponatremia, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory loss, tremor, sensory changes, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, visual disturbances, visual impairment, pupillary constriction, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary tract disorders, erectile dysfunction, weakness, chest pain, emotional abnormality, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, feeling of warmth, weight loss, elevated serum creatinine, anaphylactic reactions, effects on unstable emotions, delirium, suicidal thoughts, muscular hypertonicity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, thrombocytopenia, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, congestive heart failure, vertigo, confusion, exacerbation of migraine, involuntary muscle contractions, respiratory distress, coughing, bronchitis, urinary retention, frequency of urination, abnormal kidney function tests, oliguria, increased rash, urticaria, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, decreased appetite, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, palpitations, hypertension, arrhythmia, tachycardia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, elevated cholesterol, weight loss, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, vertigo, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory syndrome, dry mouth, agitation, irritability, excessive motor activity, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal CNS reactions, urticaria, rash, bronchospasm, toxic skin necrosis, opioid-induced hyperalgesia, symptoms of acute or chronic adrenal insufficiency (severe abdominal pain, nausea, vomiting, hypotension, extreme fatigue, decreased appetite, weight loss)

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air from entering and kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.